Biocon Pumps Up For Adalimumab US Debut Amid Payer ‘Steady State’

 
• By Anju Ghangurde
  
Biocon primes for biosimilar Humira debut • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip